9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Hoffmann-La Roche
Cellectar Biosciences, Inc.
Endeavor Biomedicines, Inc.
Eli Lilly and Company
Servier
Jazz Pharmaceuticals
Turning Point Therapeutics, Inc.
Novartis
Eli Lilly and Company
Blueprint Medicines Corporation
Istari Oncology, Inc.
Lumos Pharma
Deciphera Pharmaceuticals, LLC
Eisai Inc.
Novartis
Bristol-Myers Squibb
Celgene
DNAtrix, Inc.
Celgene
Biogen
Lumos Pharma
Shenzhen BinDeBio Ltd.
DNAtrix, Inc.
Novartis
Merck Sharp & Dohme LLC
Laboratorio Elea Phoenix S.A.
GE Healthcare
INSYS Therapeutics Inc
TransMolecular
MediGene